Michael Nelson
Amministratore Delegato presso Intrommune Therapeutics, Inc.
Profilo
Michael Nelson is the founder of Intrommune Therapeutics, Inc. He currently holds the title of Co-President & Chief Executive Officer, which he has held since the company's founding in 2015.
Posizioni attive di Michael Nelson
| Società | Posizione | Inizio |
|---|---|---|
Intrommune Therapeutics, Inc.
 Intrommune Therapeutics, Inc. MiscellaneousMiscellaneous Intrommune Therapeutics, Inc. operates as a biopharmaceutical company. The firm develops oral mucosal immunotherapy(OMIT) platform for food allergies. The company was founded by Michael Nelson and William Reisacher in 2015 and is headquartered in New York, NY. | Amministratore Delegato | 01/10/2015 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 1 |
|---|---|
Intrommune Therapeutics, Inc.
Intrommune Therapeutics, Inc. MiscellaneousMiscellaneous Intrommune Therapeutics, Inc. operates as a biopharmaceutical company. The firm develops oral mucosal immunotherapy(OMIT) platform for food allergies. The company was founded by Michael Nelson and William Reisacher in 2015 and is headquartered in New York, NY. | Miscellaneous |
- Borsa valori
- Insiders
- Michael Nelson
